Pamica appoints Joacim Lindoff CEO, replacing founder Jan-Olof Svensson
Reuters2026/08/17 19:38- Pamica appointed Joacim Lindoff CEO, president effective Aug. 19.
- Lindoff most recently served as deputy CEO, COO; previously led medical technology group Arjo as CEO for eight years.
- Founder Jan-Olof Svensson will step down as CEO to lead the group’s acquisition activities.
- Nomination committee plans to propose Svensson for election to the board at a forthcoming general meeting.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic's annualized revenue in July reportedly exceeded $65 billions, more than seven times higher than at the end of last year.
Last Friday, it was reported that Anthropic achieved preliminary revenue of over 11.5 billions USD in Q2, representing a year-on-year increase of nearly 14 times, and has already reached profitability on an adjusted operating income basis.
Vamos publishes presentation for Aug. 17 extraordinary shareholder meeting
Zevra Therapeutics Chief Legal & Compliance Rahsaan Thompson sells 42,666 shares for $474,781.44